Copyright © 1998 by the European Society of Cardiology.
Atrial fibrillation: current knowledge and recommendations for management
on behalf of the Working Group on Arrhythmias of the The European Society of Cardiology
accepted March 12, 1998
Atrial fibrillation, a commonly encountered arrhythmia, has in recent years, been the subject of increased interest and intensive clinical research. There is also increasing awareness that atrial fibrillation is a major cause of embolic events which in 75% of cases are complicated by cerebrovascular accidents[1,2]. Atrial fibrillation is often associated with heart disease but a significant proportion of patients (about 30%) have no detectable heart disease[3]. Symptoms, occasionally disabling, haemo-dynamic impairment and a decrease in life expectancy are among the untoward effects of atrial fibrillation, resulting in an important morbidity, mortality and an increased cost for the health care provider[4].
The Working Group of Arrhythmias of the European Society of Cardiology created a Study Group on Atrial Fibrillation in order to establish recommen-dations for the better management of this arrhythmia and to promote multicentre studies. The purpose of this paper is to briefly outline the state of our knowledge on the clinical presentation, the causes, the mechanisms and therapeutic approaches currently available and to propose recommendations for management. Although atrial flutter can coexist with atrial fibrillation, it is considered a different arrhythmia and will not be covered in the present paper.
Key Words: atrial fibrillation thromboembolism anti-arrythmic agents anticoagulant therapy
This Report represents the opinion of the Study Group on Atrial Fibrillation and does not necessarily reflect the opinion of the ESC.
f2 Correspondence:Samuel Lévy MD, FESC, Division of Cardiology, Hôpital Nord, Marseille, 13015 France.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. G. Cosio, E. Aliot, G. L. Botto, H. Heidbuchel, C. J. Geller, P. Kirchhof, J.-C. De Haro, R. Frank, J. P. Villacastin, J. Vijgen, et al. Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode Europace, January 1, 2008; 10(1): 21 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B Friedrich and M. Bohm MANAGEMENT OF END STAGE HEART FAILURE Heart, May 1, 2007; 93(5): 626 - 631. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF] |
||||
![]() |
P. Milliez, N. DeAngelis, C. Rucker-Martin, A. Leenhardt, E. Vicaut, E. Robidel, P. Beaufils, C. Delcayre, and S. N. Hatem Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction Eur. Heart J., October 2, 2005; 26(20): 2193 - 2199. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, G. Monnig, K. Wasmer, A. Heinecke, G. Breithardt, L. Eckardt, and D. Bocker A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA) Eur. Heart J., July 1, 2005; 26(13): 1292 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, K. Swedberg, Writing Committee:, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. A. Smiseth, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur. Heart J., June 1, 2005; 26(11): 1115 - 1140. [Full Text] [PDF] |
||||
![]() |
R. Mitra and E.W. Leatham Admissions with atrial fibrillation: disease patterns and outcomes in a District General Hospital QJM, February 1, 2005; 98(2): 153 - 154. [Full Text] [PDF] |
||||
![]() |
L Boodhoo, G Bordoli, A R Mitchell, G Lloyd, N Sulke, and N Patel The safety and effectiveness of a nurse led cardioversion service under sedation Heart, December 1, 2004; 90(12): 1443 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
J L Martins, K F Fox, D A Wood, D C Lefroy, T J Collier, and N S Peters Rapid access arrhythmia clinic for the diagnosis and management of new arrhythmias presenting in the community: a prospective, descriptive study Heart, August 1, 2004; 90(8): 877 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
R A Archbold and R J Schilling Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature Heart, February 1, 2004; 90(2): 129 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Scholten, T Szili-Torok, P Klootwijk, and L Jordaens Comparison of monophasic and biphasic shocks for transthoracic cardioversion of atrial fibrillation Heart, September 1, 2003; 89(9): 1032 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gronefeld, J.R. Ehrlich, and S.H. Hohnloser Comparison of outpatient vs inpatient direct current cardioversion of atrial fibrillation: safety, efficacy and cost savings Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H19 - H24. [Abstract] [PDF] |
||||
![]() |
P. Jais, D.C. Shah, M. Hocini, L. Macle, K.-J. Choi, M. Haissaguerre, and J. Clementy Radiofrequency ablation for atrial fibrillation Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H34 - H39. [Abstract] [PDF] |
||||
![]() |
G.Q. Villani, M. Piepoli, P.E. Villani, and A. Capucci Anticoagulation in atrial fibrillation: what is certain and what is to come Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H45 - H50. [Abstract] [PDF] |
||||
![]() |
P. Touboul, J. Brugada, A. Capucci, H. J.G.M. Crijns, N. Edvardsson, and S. H. Hohnloser Dronedarone for prevention of atrial fibrillation: A dose-ranging study Eur. Heart J., August 2, 2003; 24(16): 1481 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gronefeld and S. H. Hohnloser Rhythm or Rate Control in Atrial Fibrillation: Insights from the Randomized Controlled Trials Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2003; 8(1_suppl): S39 - S44. [Abstract] [PDF] |
||||
![]() |
S K S Lairikyengbam, M H Anderson, and A G Davies Present treatment options for atrial fibrillation Postgrad. Med. J., February 1, 2003; 79(928): 67 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Essebag, T. Hadjis, R. W. Platt, and L. Pilote Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction J. Am. Coll. Cardiol., January 15, 2003; 41(2): 249 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Langerveld, N. M. van Hemel, J. C. Kelder, J. M. P. G. Ernst, H. W. M. Plokker, and W. Jaarsma Long-term follow-up of cardiac rhythm after percutaneous mitral balloon valvotomy: Does atrial fibrillation persist? Europace, January 1, 2003; 5(1): 47 - 53. [Abstract] [PDF] |
||||
![]() |
S. Levy, A. J. Camm, S. Saksena, E. Aliot, G. Breithardt, H. Crijns, W. Davies, N. Kay, E. Prystowsky, R. Sutton, et al. International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Europace, January 1, 2003; 5(2): 119 - 122. [PDF] |
||||
![]() |
Z. Szabo, G. Kakuk, T. Fulop, J. Matyus, J. Balla, I. Karpati, A. Juhasz, C. Kun, Z. Karanyi, and I. Lorincz Effects of haemodialysis on maximum P wave duration and P wave dispersion Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1634 - 1638. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Deneke, K. Khargi, P. H. Grewe, S. von Dryander, F. Kuschkowitz, T. Lawo, K.-M. Muller, A. Laczkovics, and B. Lemke Left atrial versus bi-atrial maze operation using intraoperatively cooled-tip radiofrequency ablation in patients undergoing open-heart surgery: Safety and efficacy J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1644 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jais, R. Weerasooriya, D. C. Shah, M. Hocini, L. Macle, K.-J. Choi, C. Scavee, M. Haissaguerre, and J. Clementy Ablation therapy for atrial fibrillation (AF): Past, present and future Cardiovasc Res, May 1, 2002; 54(2): 337 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Olivotto, F. Cecchi, S. A. Casey, A. Dolara, J. H. Traverse, and B. J. Maron Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy Circulation, November 20, 2001; 104(21): 2517 - 2524. [Abstract] [Full Text] [PDF] |
||||
![]() |
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923. [PDF] |
||||
![]() |
V. Frykman, B. Beerman, L. Ryden, and M. Rosenqvist Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications Eur. Heart J., October 2, 2001; 22(20): 1954 - 1959. [Abstract] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266. [Full Text] [PDF] |
||||
![]() |
Task Force for the Diagnosis and Treatment of Chro, W. J. Remme, and K. Swedberg Guidelines for the diagnosis and treatment of chronic heart failure Eur. Heart J., September 1, 2001; 22(17): 1527 - 1560. [PDF] |
||||
![]() |
O. D. Pedersen, H. Bagger, N. Keller, B. Marchant, L. Kober, and C. Torp-Pedersen Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy Circulation, July 17, 2001; 104(3): 292 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.A. Wood, K.F. Fox, and S.R. Gibbs Rapid cardiology--for chest pain, breathlessness and palpitations QJM, April 1, 2001; 94(4): 177 - 178. [Full Text] [PDF] |
||||
![]() |
H. H. Veloso Long-term efficacy of epicardial radiofrequency ablation of chronic atrial fibrillation during mitral valve surgery Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 231 - 232. [Full Text] [PDF] |
||||
![]() |
F. Lombardi, A. Colombo, B. Basilico, R. Ravaglia, M. Garbin, D. Vergani, P. M. Battezzati, and C. Fiorentini Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion J. Am. Coll. Cardiol., January 1, 2001; 37(1): 157 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Poldermans, J. J. Bax, A. Elhendy, F. Sozzi, E. Boersma, I. R. Thomson, and L. J. Jordaens Long-term Prognostic Value of Dobutamine Stress Echocardiography in Patients With Atrial Fibrillation Chest, January 1, 2001; 119(1): 144 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gasparini, A. Bonso, S. Themistoclakis, F. Giada, and A. Raviele Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up Europace, January 1, 2001; 3(2): 90 - 95. [Abstract] [PDF] |
||||
![]() |
P. Ricard, S. Levy, G. Boccara, E. Lakhal, and G. Bardy External cardioversion of atrial fibrillation: comparison of biphasic vs monophasic waveform shocks Europace, January 1, 2001; 3(2): 96 - 99. [Abstract] [PDF] |
||||
![]() |
M. J. P. Raatikainen, T. E. Morey, P. Druzgala, P. Milner, M. D. Gonzalez, and D. M. Dennis Potent and Reversible Effects of ATI-2001 on Atrial and Atrioventricular Nodal Electrophysiological Properties in Guinea Pig Isolated Perfused Heart J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 779 - 785. [Abstract] [Full Text] |
||||
![]() |
D. Pfeiffer and B. Luderitz The right atrial/transoesophagael approach for conversion of atrial fibrillation: a hybrid method for compromise? Eur. Heart J., May 2, 2000; 21(10): 785 - 787. [PDF] |
||||
![]() |
C. Stellbrink and P. Hanrath The optimal management of cardioversion of atrial fibrillation of flutter: still a 'stunning' problem Eur. Heart J., May 2, 2000; 21(10): 795 - 798. [PDF] |
||||
![]() |
E. R. Jessurun, N. M. van Hemel, J. A. M. T. Defauw, M. A. M. Stofmeel, J. C. Kelder, A. Brutel de la Riviere, and J. M. P. G. Ernst Results of Maze Surgery for Lone Paroxysmal Atrial Fibrillation Circulation, April 4, 2000; 101(13): 1559 - 1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.U Khand, A.C Rankin, G.C Kaye, and J.G.F Cleland Systematic review of the management of atrial fibrillation in patients with heart failure Eur. Heart J., April 2, 2000; 21(8): 614 - 632. [Abstract] [PDF] |
||||
![]() |
S. Levy Cardioversion of chronic atrial fibrillation--towards a more aggressive approach Eur. Heart J., February 2, 2000; 21(4): 263 - 263. [PDF] |
||||
![]() |
B. J.J.M. Brundel, I. C. Van Gelder, R. H. Henning, A. E. Tuinenburg, L. E. Deelman, R. G. Tieleman, J. G. Grandjean, W. H. Van Gilst, and H. J.G.M. Crijns Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation Cardiovasc Res, May 1, 1999; 42(2): 443 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Levy Atrioventricular junctional ablation and pacing for paroxysmal atrial fibrillation: the Barcelona recommendations Europace, January 1, 1999; 1(1): 2 - 4. [PDF] |
||||













